Lancet Infectious Diseases Submission Process

Is the practical implication immediate?

The journal wants to know what changes in clinical care, surveillance, policy, or preparedness if this paper is true.

Is the methodology strong enough?

High-consequence infectious-disease claims attract careful scrutiny. Weak comparative design, underpowered cohorts, or unstable inference are hard to hide.

Is the audience global enough?

Many infectious-disease studies are important locally. This journal is testing whether the lesson travels more broadly.

Does the package feel current and complete?

If the work feels late, partial, or underframed, editorial enthusiasm drops quickly.

A strong package usually shows:

• a question that matters beyond one local setting
• clean methods and appropriately bounded claims
• clear clinical or public-health consequence
• figures that surface the main result quickly
• writing that does not confuse urgency with proof

The paper should feel like a consequential infectious-disease article, not a strong local report dressed up for a larger stage.

The first stall point is scope. Authors often have a real infectious-disease signal, but the paper is still too local or too narrow in implication. The second is timing. A study can be scientifically competent but miss the journal if the window of broader urgency has already passed. The third is overclaiming. Editors are especially sensitive when the abstract promises policy or treatment consequences that the evidence only partly supports.

The cover letter should help the editor understand consequence and fit quickly. The best version usually:

• states the infectious-disease problem in a way that immediately signals scale
• explains why the result matters beyond one institution or one outbreak setting
• shows why the paper belongs in Lancet Infectious Diseases rather than a narrower specialty journal
• avoids trying to create urgency through rhetoric alone

That tone matters. Editors trust packages that sound disciplined more than ones that sound breathless.

Before submission, assume reviewers will ask some version of:

• is the policy or treatment consequence really this large
• does the dataset justify a global conclusion
• are access, equity, or implementation issues being ignored
• is the paper late relative to the urgency it claims

If the manuscript answers those questions on its own, it has a better chance of surviving both editorial triage and review.

Run one last editorial test:

• does the abstract make the consequence clear without overclaiming
• would an editor believe the findings matter outside one local setting
• do the figures support the most policy- or treatment-relevant conclusion
• are implementation or access questions addressed where they obviously matter
• if the urgency disappeared tomorrow, would the paper still feel important

That check separates durable significance from a merely timely frame.

Try explaining the study to an infectious-disease editor in one sentence. If the value only sounds important once you add urgency, institutional prestige, or lots of context, the paper may still be too narrow. If the implication sounds important even after you strip away rhetorical pressure, the package is much closer to ready.

The strongest packages usually avoid three visible problems:

• local framing that never becomes globally relevant
• outbreak or surveillance urgency that is being used to cover weak inference
• implementation claims that sound larger than the evidence base

If those problems are already edited out before upload, the package tends to read as much more stable and much more publishable.